Technical guide

Liposomal formulation, stability and packaging

Selecting a suitable ingredient is the beginning of product development. Combining it with other components, manufacturing processes and packaging creates a new formulation. Reviewing a liposomal ingredient dossier in that wider context helps identify the right development questions before moving to production scale.

Ingredient shelf life is not finished-product shelf life

The storage conditions and shelf life declared for an ingredient relate to its defined product and packaging conditions. They cannot simply be assigned to a new liquid mixture, sachet or capsule. Appropriate stability assessment should consider the finished composition, manufacturing process and package.

A 2024 liposomal vitamin C manufacturing study illustrates the assessment of processing parameters alongside the resulting structure. Such development results should not be treated as ready-made operating instructions for another manufacturer or formulation.

Source: FDA (2018) — Liposome Drug Products; technical framework for process and stability; Romano et al. (2024) — Liposomal vitamin C manufacturing and stability research

Conditions to clarify before manufacture

TopicDevelopment question
Temperature and durationAt what stage, and for how long, will the ingredient encounter heat?
pH and other componentsAre the intended medium, salts and excipients compatible with the carrier?
Mixing and processingDoes the proposed process match the manufacturer’s recommended conditions?
Moisture and oxygenWhich exposures need to be managed during manufacture and storage?
Filling and packagingIs the selected material suitable for the product and intended use period?

Source: FDA (2018) — Liposome Drug Products; technical framework for process and stability

A liquid product requires more than an appearance check

A 2015 study of liposomal components in orange juice illustrates the joint assessment of heat treatment, composition and sensory properties. Its findings do not demonstrate identical heat tolerance for all liposomal ingredients.

Sample work can track appearance, taste and odour, usability and measurable quality parameters within one plan. An ingredient that appears suitable on its own still needs assessment in the intended final mixture.

Source: Marsanasco et al. (2015) — Liposomal components assessed in an orange juice matrix

Do not leave packaging until the end

Requirements concerning moisture, light and oxygen depend on product characteristics. There is no single bottle, sachet or storage condition suitable for every liposomal product. Packaging selection should progress alongside manufacturer data and finished-product evaluation.

Use after opening for liquids, repeated opening for powders and shipping conditions may also be relevant to the plan. Label storage instructions should be consistent with the available evidence.

Source: FDA (2018) — Liposome Drug Products; technical framework for process and stability

Planning pilot work with Biontera

Sharing the target format, production flow and packaging options early makes ingredient assessment more practical. We can review the dossier and sample together to establish the topics that development needs to address.

  • Review the ingredient specification and manufacturer’s conditions of use.
  • Prepare the intended formula at laboratory or pilot scale.
  • Identify suitable chemical, physical and microbiological quality parameters.
  • Assess the finished product in the selected packaging and storage conditions.
  • Revisit changed process conditions when moving to manufacturing scale.

Common questions

Do all liposomal ingredients require refrigeration?

No. Storage conditions depend on composition, form, packaging and stability data. Review the instructions for the particular product.

Can liposomal ingredients be heat processed?

Suitability must be assessed for the particular ingredient and process. Temperature, duration and the surrounding medium all matter.

Does an ingredient CoA establish finished-product shelf life?

No. A CoA reports stated quality results for the relevant batch. Finished-product shelf life depends on its own formulation, packaging and evaluation data.

Explore the portfolio

From understanding to selection.

Let’s assess your next formulation.

Share your dosage form, intended amount per serving and estimated annual requirement. We can plan ingredient selection, technical documentation and sample evaluation together.

Discuss documents and samples